CMS Drug Pricing Guidance Proposed In Medicaid Commission Report

The Centers for Medicare & Medicaid Services should issue guidance on how drug manufacturers determine pricing, the Medicaid Commission's reform proposal recommends

More from Archive

More from Pink Sheet